Product News
MammaTyper® Enables More Precise Prediction of the Response to Neoadjuvant Chemotherapy Compared to Manual or Digitalized IHC
First comparison of a biomarker analysis by RT-qPCR (MammaTyper®) versus visual or computer-assisted immunohistochemistry (IHC) in subtyping mammary carcinomas